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ABSTRACT 
 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to evaluate the genotoxic potential of two flavouring substances from subgroup 5.2 of 
FGE.19 in the Flavouring Group Evaluation 224  (FGE.224). The Flavour Industry has provided additional 
genotoxicity studies for one of the two substances in FGE.224, namely 5-methyl-2-thiophenecarbaldehyde [FL-
no: 15.004]. The data requested by EFSA for the other substance, 3-acetyl-2,5-dimethylthiophene [FL-no: 
15.024] of FGE.224 will be provided subsequently according to the Flavour Industry. Based on the new data the 
Panel concluded that 5-methyl-2-thiophenecarbaldehyde does not give rise to concern with respect to 
genotoxicity and can accordingly be evaluated using the Procedure. For the other substance in subgroup 5.2, 3-
acetyl-2,5-dimethylthiophene, the requested genotoxicity data are still pending and no conclusion could be 
drawn in the present FGE. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following a request from the European Commission the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids  (CEF Panel) was asked to deliver a scientific  opinion on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000. These flavouring substances are listed in the Register, which was adopted by 
Commission Decision 1999/217/EC and its consecutive amendments. 
The present Flavouring Group Evaluation 224 (FGE.224), corresponding to subgroup 5.2 of FGE.19, 
concerns two α,β-unsaturated thiophenes. The two substances in the present evaluation are one α,β-
unsaturated aldehyde and one α,β-unsaturated ketone, structures which are considered to be structural 
alerts for genotoxicity and the data on genotoxicity previously available for these two substances did 
not rule out the concern for genotoxicity. 
The Panel did not find that genotoxicity data for either of the substances in subgroup 5.2 could be used 
for reading across to the other substance in the subgroup; therefore  genotoxicity data have been 
requested for both substances, according to the test strategy worked out by the Panel. 
The Flavour Industry has  provided additional genotoxicity data for one 5-methyl-2-
thiophenecarbaldehyde [FL-no: 15.004] of the two substances in FGE.224. The requested data for the 
other substance,  3-acetyl-2,5-dimethylthiophene  [FL-no: 15.024],  will be provided subsequently, 
according to the Flavour Industry. 
Based on the data submitted the Panel concluded that 5-methyl-2-thiophenecarbaldehyde  [FL-no: 
15.004] does not give rise to concern with respect to genotoxicity and can accordingly be evaluated 
using the Procedure.  For the other substance in subgroup 5.2, 3-acetyl-2,5-dimethylthiophene [FL-no: 
15.024]., the requested genotoxicity data are still pending and no conclusion could be drawn in the 
present FGE. Flavouring Group Evaluation 224 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
In the 26
th  Plenary meeting of the AFC Panel on 27-29 November 2007, EFSA discussed the 
Flavouring Group Evaluation 19 (FGE.19). FGE.19 contains those flavouring substances which are 
α,β-unsaturated aldehydes or ketones and their precursors which could give rise to such carbonyl 
substances via hydrolysis and/or oxidation. The α,β-unsaturated  aldehyde and ketone structure is 
considered by the Panel to be a structural alert for genotoxicity. FGE.19 was divided into subgroups. 
For subgroup 5.2, which contains 2 flavouring substances, EFSA concluded that there is a need for 
additional information before conclusions on the substances in this subgroup can be reached. 
Information on flavouring substance 5-methyl-2-thiophenecarbaldehyde (FL-no: 15.004) has now 
been submitted by the European Flavour Association. 
The Commission asks EFSA to evaluate this new information and depending on the outcome proceed 
to the full evaluation of this flavouring substance. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests the European Food Safety Authority to carry out a safety 
assessment on 5-methyl-2-thiophenecarbaldehyde [FL-no: 15.004], in accordance with Commission 
Regulation (EC) N° 1565/2000. Flavouring Group Evaluation 224 
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ASSESSMENT 
1.  History of the Evaluation 
Regulation (EC) N° 2232/96 of the European Parliament and the Council (EC, 1996) lays down a 
procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC  (EC, 1999), as last amended by Commission Decision 2009/163/EC (EC, 
2009). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) N° 1565/2000 (EC, 2000) which is broadly based on the 
opinion of the Scientific Committee on Food (SCF, 1999). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) N° 622/2002 (EC, 
2002).  
The Union list of flavourings and source materials is established in Commission Regulation (EC) N° 
872/2012 (EC, 2012). 
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register 
being α,β-unsaturated aldehydes or ketones and precursors which could give rise to such carbonyl 
substances via hydrolysis and / or oxidation (EFSA, 2008a). 
The α,β-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity. The Panel 
noted that there were limited genotoxicity data on these flavouring substances but that positive 
genotoxicity studies were identified for some substances in the group. 
The α,β-unsaturated carbonyls were subdivided into subgroups on the basis of structural similarity 
(EFSA, 2008a). In an attempt to decide which of the substances could go through the Procedure, a 
(quantitative) structure-activity relationship ((Q)SAR)  prediction of the genotoxicity of these 
substances was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFI 
MultiCASE Models and ISS Local Models, (Gry et al., 2007)). 
The Panel noted that for most of these models internal and external validation has been performed, but 
considered that the outcome of these validations was not always extensive enough to appreciate the 
validity of the predictions of these models for the α,β-unsaturated carbonyls. Therefore, the Panel 
considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and decided not 
to take substances through the Procedure based on negative (Q)SAR predictions only. 
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni and Netzeva, 
2007a; Benigni and Netzeva, 2007b)  and four DTU-NFI MultiCASE Models (Gry et al., 2007; 
Nikolov et al., 2007) and the fact that there are available data on genotoxicity, in vitro and in vivo, as 
well as data on carcinogenicity for several substances.  
Based on these data the Panel decided that 15 subgroups (1.1.1, 1.2.1, 1.2.2, 1.2.3, 2.1, 2.2, 2.3, 2.5, 
3.2, 4.3, 4.5, 4.6, 5.1, 5.2 and 5.3) (EFSA, 2008a) could not be evaluated through the Procedure due to 
concern with respect to genotoxicity. Corresponding to these subgroups, 15 Flavouring Group 
Evaluations (FGEs) were established, FGE.200, 204, 205, 206, 207, 208, 209, 211, 215, 219, 221, 222, 
223, 224 and 225). 
For 11 subgroups the Panel decided, based on the available genotoxicity data and (Q)SAR predictions, 
that a further scrutiny of the data should take place before requesting additional data on genotoxicity 
from the Flavouring Industry. These subgroups were evaluated in FGE.201, 202, 203, 210, 212, 213, Flavouring Group Evaluation 224 
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214, 216, 217, 218 and 220. For the substances in FGE.202, 214 and 218 it was concluded that a 
genotoxic potential could be ruled out and accordingly these substances will be evaluated using the 
Procedure. For all or some of the substances in the remaining FGEs, FGE.201, 203, 210, 212, 213, 
216, 217 and 220 the genotoxic potential could not be ruled out. 
To ease the data retrieval of the large number of structurally related α,β-unsaturated substances in the 
different subgroups for which additional data are requested, EFSA has worked out a list of 
representative substances for each subgroup (EFSA, 2008c). Likewise an EFSA genotoxicity expert 
group has worked out a test strategy to be followed in the data retrieval for these substances (EFSA, 
2008b).  
The Flavouring Industry has been requested to submit additional genotoxicity data according to the list 
of representative substances and test strategy for each subgroup.  
The Flavouring Industry has now submitted additional data and the present FGE concerns the 
evaluation of some of these data requested on genotoxicity. 
2.  Presentation of the substances in the Flavouring Group Evaluation 224 
2.1.  Description 
The present Flavouring Group Evaluation 224 (FGE.224), corresponding to subgroup 5.2 of FGE.19, 
concerns  two  α,β-unsaturated  thiophene  derivatives,  one  α,β-unsaturated aldehyde,  5-methyl-2-
thiophenecarbaldehyde [FL-no: 15.004]  and  one  α,β-unsaturated ketone,  3-acetyl-2,5-
dimethylthiophene [FL-no: 15.024].  The  α,β-unsaturated aldehyde and ketone structures are 
considered to be structural alerts for genotoxicity (EFSA, 2008a)  and the data on genotoxicity 
previously available did not rule out this concern for genotoxicity. 
Furthermore, the Panel did not find that the chemical structure of the two substances allowed for a 
read across between genotoxicity data for the two substances and accordingly the Flavour Industry 
was requested to submit data for each of the substances in subgroup 5.2. The structures of the two 
substances in Subgroup 5.2 are shown in Tables 1 and 2.  
The two substances have previously been evaluated by the JECFA at their 59
th meeting (JECFA, 
2002a, 2003). A summary of their current evaluation status by the JECFA and the outcome of this 
consideration is presented in Table 3. 
2.2.  Representative substances for subgroup 5.2 of FGE.19 
As the Panel did not find that the chemical structure of the two substances allowed for a read across 
between genotoxicity data, the Flavour Industry was requested to submit genotoxicity data for each of 
the substances in subgroup 5.2 in accordance with the test strategy (EFSA, 2008b). The chemical 
structures of the two substances in subgroup 5.2 are shown in Table 1. 
Table 1:   Substances in subgroup 5.2 of FGE.19  
FL-no  
JECFA-no  
EU Register name   Structural formula   FEMA no  
CoE no  
CAS no  
15.004 
1050  
5- Methyl-2-thiophenecarbaldehyde 
S
O
 
3209 
2203 
13679-70-4 
15.024 
1051 
3-Acetyl-2,5-dimethylthiophene 
S
O
 
3527 
11603 
2530-10-1 
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3.  Additionally genotoxicity data submitted for subgroup 5.2 
The Industry has submitted genotoxicity studies for one, 5-methyl-2-thiophenecarbaldehyde [FL-no: 
15.004], of the two substances in this subgroup (EFFA, 2012). According to the Industry additional 
genotoxicity data for the other substance [FL-no: 15.024] will be submitted on a later stage.  
The new data submitted for 5-methyl-2-thiophenecarbaldehyde [FL-no: 15.004] covers both in vitro 
and in vivo genotoxicity assays. 
3.1.  In vitro data 
5-Methyl-2-thiophenecarbaldehyde [FL-no: 15.004] 
3.1.1.  Bacterial Reverse Mutation Assay 
5-Methyl-2-thiophenecarbaldehyde was tested for the induction of gene mutations in the Salmonella 
typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 both in the absence and in the 
presence of Aroclor induced rat liver S9-mix. Three independent experiments were performed 
(Beevers, 2009). An initial toxicity range  finding experiment was carried out in the absence and 
presence of S9-mix in strain TA100. Six concentrations were tested in the concentration range 1.6 - 
5000 µg/plate of 5-methyl-2-thiophenecarbaldehyde. Negative (solvent) and positive controls were 
included. Toxicity, evident as a decrease in revertant count, was apparent on all plates treated at 1000 
µg/plate and above in the absence and presence of S9-mix, but revertant counts were obtained from at 
least four different concentrations, and these data were included as part of experiment 1. 
In the first main experiment 5-methyl-2-thiophenecarbaldehyde was tested in the remaining 4 strains 
in the absence and presence of S9-mix using the plate incorporation methodology at concentrations 
ranging from 0.32 -  1000 µg/plate. Based on the range finding study the maximum tested 
concentration was reduced to 1000 µg/plate. Evidence of toxicity was observed at 200 μg/plate and 
above in strains TA1537 and TA102, in the presence of S9-mix, and at 1000 μg/plate in strains TA98 
and TA102 in the absence of S9-mix and in strain TA98 and TA1535 in the presence of S9-mix. 
However, revertant counts were obtained from six different concentrations and so the data were 
considered valid for evaluation. 
In a second experiment, treatments of all the tester strains were performed in the absence and presence 
of S9-mix. For each strain the highest tested concentration was based on toxicity in the first 
experiment and narrowed concentration ranges were employed. In addition, all treatments in the 
presence of S9-mix were further modified by the inclusion of a 1-hour pre-incubation step. Clear 
evidence of toxicity was observed in strains TA98 and TA102 following treatment at the maximum 
test concentration in both the absence and presence of S9-mix, and in the strain TA1537 following 
treatment at the maximum concentration in the presence of S9-mix. However, toxicity was not seen at 
the concentrations tested in TA100 and TA1535 in the presence and absence of S9-mix or in TA1537 
in the absence of S9-mix, and therefore it was considered that higher concentrations should be 
evaluated. For the other strains data from a sufficient number of concentrations were obtained. 
In the third experiment, 5-methyl-2-thiophenecarbaldehyde was tested in TA100 and TA1535 in the 
absence and presence of S9-mix and in TA1537 in the absence of S9-mix at 156.25 - 5000 µg/plate. 
Following these treatments, evidence of toxicity was observed at 2500 μg/plate and above in strains 
TA100 and TA1535 in the presence of S9-mix only. 
No statistically significant increases in revertant numbers were observed in any of the tester strains 
that were both concentration-related and clearly reproducible. Some small increases in revertant 
numbers were observed in strain TA1535 in the absence of S9-mix, but these were sporadic, not 
concentration related and not reproducible. They were therefore considered to be chance occurrences 
and not a compound-related effect and therefore not biological relevant. Flavouring Group Evaluation 224 
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It was concluded that 5-methyl-2-thiophenecarbaldehyde did not induce mutation in five histidine-
requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of S. typhimurium when tested under 
the conditions of this study. These conditions included treatments at concentrations up to either the 
limit of toxicity or 5000 μg/plate (the maximum recommended concentration according to current 
regulatory guidelines), in both the absence and in the presence of a rat liver metabolic activation 
system (S9-mix). 
The results of the in vitro studies are summarised in Table 4. 
3.1.2.  In vitro micronucleus assays 
5-Methyl-2-thiophenecarbaldehyde was tested for the induction of chromosome damage and potential 
aneugenic effects in an in vitro micronucleus assay using duplicate human peripheral blood 
lymphocytes prepared from pooled blood from two healthy volunteers in two separate experiments. 
Treatments were performed both in the absence and presence of Aroclor 1254 induced rat liver S9-mix 
(Lloyd, 2011). Experiment 1 was conducted using blood from female donors and Experiment 2 was 
conducted using blood from male donors. 
Treatment with 5-methyl-2-thiophenecarbaldehyde was conducted 48 hours after  culture initiation 
(stimulation by phytohaemagglutinin). 
A preliminary toxicity range finding experiment was conducted with S9-mix and 3 hours treatment 
and without S9-mix with 3 and 24 hours treatment. Toxicity was evaluated as the effect of treatment 
on the  Replication  Index  (RI).  Twelve  concentrations  from  4.6  to  1262  μg/mL  were  tested.  The 
concentrations selected for the main experiments were based on toxicity data from this preliminary 
test. 
In Experiment 1 (female donors) cells were exposed to 5-methyl-2-thiophenecarbaldehyde for 3 hours 
and 21 hours recovery (3 + 21) both with and without S9-mix. In addition, a continuous 24 hours 
treatment without recovery (24 + 0) was performed without S9 mix. All cultures were sampled 24 
hours after the beginning of treatment (i.e. 72 hours after culture initiation). The concentrations 
selected for evaluation in the absence of S9-mix and 3 hours exposure were 600, 900 and 1000 μg/mL 
and in the presence of S9-mix and 3 hours exposure 50, 60 and 70 μg/mL. After 24 hours exposure 
cultures exposed to 120 μg/mL, 240 μg/mL, 300 μg/mL and 350 μg/mL were evaluated. Relevant 
positive and negative controls were included in all experiments. At the first test conditions (3 + 21 
hours without S9-mix) no significant increases in the frequency of micronucleated binucleate cells 
(MNBN) were observed relative to concurrent vehicle controls at all concentrations analysed. 
Furthermore, the MNBN cell frequencies in all treated cultures under this treatment condition fell 
within the 95
th percentile of the normal range. 
In the 3 + 21 hours treatment condition with S9-mix the frequency of MNBN cells were significantly 
higher (1.05 %, 1.03 % and 1.33 % at 50, 60 and 70 μg/mL respectively) (p ≤ 0.001) than concurrent 
controls (0.31 %) at all concentrations analysed. The initial analysis of 1000 binucleate cells/culture 
revealed increased MNBN cell frequencies that exceeded the 95
th
 percentile of the normal range for 
female donors in one of the two replicate cultures at 50 and 60 μg/mL and in both replicate cultures at 
70 μg/mL. Following the additional analysis of 1000 binucleate cells/culture from the vehicle controls 
and the test concentrations, the frequencies of MNBN cells were still significantly higher (p  ≤ 0.001) 
than those observed in concurrent controls at all three concentrations analysed. The MNBN cell 
frequencies in one replicate culture at 60 μg/mL and in both replicate cultures at 70 μg/mL (1.33 %) 
exceeded the 95
th
 percentile of the normal range (0.1 - 1.2 %), however, both cultures at 50 μg/mL 
(1.05 %) fell within the normal range. These observations are indicative of a weak induction of 
micronuclei.  
As a follow up of this positive result a second experiment was performed with lymphocytes from male 
donors to explore whether the weak induction of micronuclei that was observed in Experiment 1 in the 
presence of S9-mix could be due to the low MN frequencies in control cultures from female blood Flavouring Group Evaluation 224 
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donors. Following treatment for 3 hours in the presence of S9-mix with 5-methyl-2-
thiophenecarbaldehyde at concentrations of 50 μg/mL, 60 μg/mL, 70 μg/mL and 80 μg/mL, followed 
by 21 hours recovery, and analysis of 1000 binucleate cells/culture, the frequencies of MNBN cells 
(0.9 %) were significantly higher (p  ≤  0.001) at 70 μg/mL compared to concurrent vehicle controls 
(0.30 %). The MNBN cell frequencies in single replicate cultures at 70 and 80 μg/mL exceeded the 
95
th
 percentile of the normal range for male donors (0.0 - 0.7 %) but the MNBN frequency at 80 
μg/mL fell within the normal range. There was a concentration-dependent MN response from 50 – 70 
μg/mL,  with  70  μg/mL  exceeding  the  normal  range  (0.90  %).  An  additional  1000  binucleate 
cells/culture were analysed, and as a result of the additional scoring the MNBN cell frequencies were 
significantly higher (p  ≤ 0.05) than concur rent vehicle controls at the three highest concentrations 
analysed (60, 70, and 80 μg/mL). However, the cumulative MNBN cell frequencies exceeded the 
normal range at only the 70.00 μg/mL concentration (and attributable to only one of two cultures). 
These results are again indicative of weak induction of micronuclei. 
In all of the different treatment conditions and separate experiments, negative control frequencies of 
MNBN were normal and were significantly increased by treatment with the positive control chemical.  
In conclusion, 5-methyl-2-thiophenecarbaldehyde weakly induced micronuclei in both male and 
female human peripheral blood lymphocytes cultures when tested for 3 + 21 hours in the presence of 
S9-mix. In the same test system 5-methyl-2-thiophenecarbaldehyde did not induce micronuclei at up 
to toxic concentrations for 3 + 21 hours and 24 + 0 hours in the absence of S9-mix. 
The results of the in vitro studies are summarised in Table 4. 
3.2.  In vivo data 
3.2.1.  In vivo Combination Assay (Comet + Micronucleus) 
On the basis of the in vitro micronucleus study reported above, as a next step to probe the genotoxic 
potential of 5-methyl-2-thiophenecarbaldehyde, a combined Comet assay and an in vivo micronucleus 
assay was carried out in rats (Beevers, 2012). This combined approach minimised the number of 
animals used in the experiments. Micronuclei were measured in bone marrow, but additionally, the 
liver was chosen as the most appropriate tissue for analysis in the Comet assay due to the fact that S9 
metabolic activation was necessary to produce weakly positive results in the in vitro micronucleus 
assay, and this organ is the primary site of metabolism. Therefore, groups of Han Wistar male rats 
were administered 5-methyl-2-thiophenecarbaldehyde via gavage and the liver and bone marrow were 
analysed for the potential induction of DNA damage. 
An initial dose range finding study was conducted to estimate the Maximum Tolerated Dose (MTD) of 
5-methyl-2-thiophenecarbaldehyde after administration by oral gavage to groups of three male and 
three female Han Wistar rats. Doses of 1000 mg/kg bw/day resulted in mortality in both male and 
female rats while at 700 mg/kg bw/day mortality occurred in the female group but not in the male 
group. On this basis, 700 mg/kg bw/day was considered the MTD in males and 500 mg/kg bw/day was 
considered the MTD in females. Although there was a slight difference in MTD between males and 
females, it was less than 2-fold. Moreover, below 700 mg/kg bw/day no gender differences in clinical 
signs of toxicity were observed. It was therefore concluded that male rats alone could be used in the 
combined Comet and micronucleus assay. 
Groups of six male Han Wistar rats were treated by oral gavage with 5-methyl-2-
thiophenecarbaldehyde at doses of 70, 350 and 700 mg/kg bw/day, including a vehicle control (5 % 
w/v aqueous methylcellulose) and a positive control (ethyl methanesulphonate, 150 mg/kg bw/day). 
Animals were dosed at 0, 24 and 45 hours. Clinical signs of toxicity and body weight were recorded at 
each time point within the study. Three hours after the last dose (i.e. at 48 hours) the liver and one 
femur were removed from each control (negative and positive) and each treated animal for analysis of 
comets and micronuclei respectively. In a satellite group of animals (N = 3 per group) dosed similarly, Flavouring Group Evaluation 224 
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0.5 mL samples of blood were taken from the jugular vein at 0.5, 1, 2, 4, 8 and 24 hours after the final 
dose in case bioanalytical proof of exposure was subsequently needed. 
No clinical signs of toxicity were observed for any animal in the treatment or control groups. No effect 
of treatment on body weight was observed. Clinical chemistry results did not present marked changes 
between treatment or control groups with two exceptions. Levels of aspartate aminotransferase were 
increased following dosing at 700 mg/kg bw/day compared to control values. Additionally, a 
histological observation of glycogen deposits in the liver of animals dosed at 350 and 700 mg/kg 
bw/day, along with changes in liver enzymes, indicate that the liver was exposed to the test article, 5-
methyl-2-thiophenecarbaldehyde. These observations indicated exposure to the target organ (the liver) 
of the Comet assay (see below).  
In the micronucleus assay femoral bone marrow was filtered through cellulose columns to remove 
the majority of nucleated cells, smears were made, fixed and stained with acridine orange. Two 
thousand polychromatic erythrocytes (PCE) per animal were scored for micronuclei under 
fluorescence microscopy. The data revealed that rats treated with 5-methyl-2-thiophenecarbaldehyde 
at all doses exhibited group mean % PCE (out of total erythrocytes) that were similar to the vehicle 
control group confirming that there was no evidence of test article-related bone marrow toxicity. 
Micronucleus frequencies in vehicle control rats were normal and were significantly increased by 
positive control treatment. Rats treated with 5-methyl-2-thiophenecarbaldehyde at all doses exhibited 
micronuclei PCE frequencies that were similar to the vehicle control group and which were considered 
consistent with the laboratory's historical data. There were no statistically significant increases in 
micronucleus frequency for any of the groups receiving the test article, compared to the concurrent 
vehicle control. There was no evidence of bone marrow toxicity, and therefore no direct evidence that 
the substance did reach the bone marrow. Therefore, no firm conclusion could be drawn on this part of 
the study. 
In the alkaline Comet assay, liver samples from all control and test article treated animals were 
washed thoroughly, cut into small pieces in Merchants solution and then pushed through bolting cloth 
to produce single cell suspensions. Four slides were prepared per single cell suspension. Single cells 
were imbedded in agarose and once gelled, all slides were placed overnight in lysis buffer. Following 
lysis 3 of the 4 slides for each tissue and animal were transferred to electrophoresis buffer (pH >13) 
and the DNA unwound for 30 minutes and were electrophoresed in the same buffer at 0.7 V/cm for 40 
minutes. After the lysis step, the 4
th slide from each tissue and animal was placed in pH 7.0 buffer for 
approximately 3 x 5 minutes and then dried. This ‘diffusion’ slide was used to estimate the degree of 
damaged cells in the cell suspensions. 
After staining with ethidium bromide tail moment and tail intensity (% DNA in tail) were obtained 
from 100 cells/animal/tissue (50 cells from each of two  slides, where possible). Each slide was 
examined for possible indications of cytotoxicity. The number of 'clouds' out of 100 cells was scored 
for each slide. 'Clouds' were not used for comet analysis. Vehicle control animals exhibited quite low 
comet scores, but significant DNA damage was induced by the positive control. The Comet analysis 
revealed that animals treated with 5-methyl-2-thiophenecarbaldehyde exhibited elevated mean tail 
intensities and tail moments compared to concurrent vehicle control animals. However, the majority of 
animals, including the vehicle controls had tail intensity  values below the laboratory’s historical 
control range and the elevated mean level was due to only one animal in each group. Thus, the data 
generated for this assay is considered to fall within the normal level of variation for the assay. In 
addition, there was no indication of dose response relationship. Therefore it is considered that 5-
methyl-2-thiophenecarbaldehyde does not induce DNA damage in the livers of rats when administered 
by oral gavage up to the MTD of 700 mg/kg bw/day. 
The results of the in vivo studies are summarised in Table 5. 
Although the Panel noted that the negative control values were extremely low (mean tail intensity of 
0.07) the assay was found acceptable because the positive control (EMS) was clearly positive (mean Flavouring Group Evaluation 224 
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tail intensity of 29.43). The main problem with a low negative control value is that a test with low 
negative control values may have a difficulty to identify DNA crosslinking substances (with two 
reactive groups). However, the chemical structure of the test substance does not indicate a crosslinking 
potential. No studies on metabolism of [FL-no: 15.004] are available to the Panel. The CEF Panel 
recently (EFSA Scientific Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (CEF),  2011) evaluated a structural related substance, 5-methyl furfural [FL-no: 13.001], in 
FGE.66Rev1 to have no concern for genotoxicity. The most likely metabolic conversions of 5-methyl 
furfural are oxidation of the aldehyde group to the carboxylic acid followed by conjugation with e.g. 
glycine or glucuronide, with rapid elimination in the urine. For furan and alkylfurans, ring opening has 
also been described, which would result in the formation of highly reactive unsaturated dialdehydes. In 
order to give an indication of whether ring opening could be possible for [FL-no: 15.004] an 
“evaluation” of the metabolism of this substance was run in a prediction programme (METEOR 
NEXUS version 1.5). In this programme no indications of ring opening were generated. Overall the 
Panel considered that the formation of a bifunctional DNA reactive metabolite is unlikely, and 
therefore concludes that this substance is not likely to have a cross-linking potential. The negative 
result of the Comet assay in the liver is considered acceptable. 
CONCLUSIONS 
5-Methyl-2-thiophenecarbaldehyde [FL-no: 15.004] did not induce mutations in a gene mutation test 
in bacteria (Ames test). It did, however, induce weak genotoxic effects in an in vitro micronucleus 
assay in the presence of S9-mix. However, these weakly positive in vitro results were not confirmed in 
an in vivo combination assay (Comet assay in liver + micronucleus assay in bone marrow) in male rats 
when dosed up to the MTD. The Panel therefore concluded that 5-methyl-2-thiophenecarbaldehyde 
[FL-no: 15.004] does not give rise to concern with respect to genotoxicity and can accordingly be 
evaluated using the Procedure.  For the other substance in subgroup 5.2, 3-acetyl-2,5-
dimethylthiophene  [FL-no: 15.024], the requested genotoxicity data are still pending  and no 
conclusion could be drawn in the present FGE. 
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SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 224  
Table 2:   Specification Summary of the Substances in the present group (JECFA, 2002b) 
FL-no 
JECFA-no 
EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
15.004 
1050 
5-Methyl-2-thiophenecarbaldehyde 
S
O
 
3209 
2203 
13679-70-4 
Liquid 
C6H6OS 
126.18 
 
Miscible 
113-114 (33hPa) 
 
NMR 
95 % 
1.574-1.586 
1.168-1.172 
15.024 
1051 
3-Acetyl-2,5-dimethylthiophene 
S
O
 
3527 
11603 
2530-10-1 
Liquid 
C8H10OS 
154.23 
Insoluble 
Miscible 
105-108 (20hPa) 
 
NMR 
96 % 
1.541-1.548 
1.084-1.088 
1)  Solubility in water, if not otherwise stated. 
2)  Solubility in 95 %  ethanol, if not otherwise stated. 
3)  At 1013.25 hPa, if not otherwise stated. 
4)  At 20°C, if not otherwise stated. 
5)  At 25°C, if not otherwise stated. 
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CURRENT SAFETY EVALUATION STATUS APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH)  
Table 3:   Summary of Safety Evaluation of the JECFA substances in the present group (JECFA, 2002a) 
FL-no 
JECFA-no 
EU Register name  Structural formula  EU MSDI 1)  
US MSDI 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 3) 
JECFA Outcome on 
the named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(genotoxicity) 
15.004 
1050 
5-Methyl-2-thiophenecarbaldehyde 
S
O
 
0.73 
0.01 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4)  Evaluated in FGE.224, 
genotoxicity concern could be 
ruled out. Can be evaluated 
using the Procedure. 
15.024 
1051 
3-Acetyl-2,5-dimethylthiophene 
S
O
 
18 
0.2 
Class II 
B3: Intake below threshold,  
B4: Adequate NOAEL exists 
4)  Evaluated in FGE.224, 
additional genotoxicity data 
required. 
1)  EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2)  Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3)  Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4)  No safety concern based on intake calculated by the MSDI approach of the named compound. 
5)  Data must be available on the substance or closely related substances to perform a safety evaluation. Flavouring Group Evaluation 224 
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GENOTOXICITY (IN VITRO)  
Table 4:   Summary of Additionally submitted in vitro genotoxicity data on [FL-no: 15.004] of subgroup 5.2 of FGE.19 
FL-no  Chemical Name  Test System in 
vitro  
Test Object   Concentrations of Substance 
and Test Conditions  
Result   Reference   Comments  
[15.004]  5-Methyl-2-
thiophenecarbaldehyde 
Reverse 
Mutation 
S. typhimurium TA98, 
TA1535, TA1537 and 
TA102 
S. typhimurium TA100 
0.32-1000 μg/plate [1,2]; 
 
 
1.6-5000 μg/plate [1,2] 
Negative  (Beevers, 2009)  Valid study performed in 
accordance with OECD 
Guideline 471 and in 
compliance with GLP. 
S. typhimurium TA98a, 
TA100b, TA102c, 
TA1535d, and TA1537e 
10.24-1000 μg/plate [2,4,a,b,c]; 
10.24-1000 μg/plate [3,5,a,d]; 
25.6-2500 μg/plate [2,4,d,e]; 
4.096-400 μg/plate [3,5,b,c,e] 
Negative 
S. typhimurium 
TA100a, TA1535b, 
TA1537c 
156.25-5000 μg /plate [2,5,a,b]; 
156.25-5000 μg /plate 
[2,4,a,b,c]; 
Negative 
Micronucleus 
Assay 
Human peripheral blood 
lymphocytes (Female 
and Male Donors) 
600-1000 μg/ml [4,6]; 
50-70 μg/mL [5,6]; 
120-350 μg/mL [4,7]; 
50-80 μg/mL [5,6] 
Weak positive 
+S9. 
(Lloyd, 2011)  Valid study performed in 
accordance with OECD 
guideline 471 and in 
compliance with GLP. 
[1] With and without S9 metabolic activation. 
[2] Plate incorporation method. 
[3] Pre-incubation method. 
[4] Without S9 metabolic activation. 
[5] With S9 metabolic activation. 
[6] 3-hour incubation with 21-hour recovery period. 
[7] 24-hour incubation with no recovery period. Flavouring Group Evaluation 224 
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GENOTOXICITY (IN VIVO)  
Table 5:   Summary of Additionally submitted in vivo genotoxicity data on [FL-no: 15.004] of subgroup 5.2 of FGE.19 
FL-no  Chemical Name  Test System in 
vivo  
Test Object / 
Administration 
Concentrations of 
Substance and Test 
Conditions  
Result   Reference   Comments  
[15.004]  5-Methyl-2-
thiophenecarbaldehyde 
Micronucleus 
Assay in rat 
bone marrow 
Han Wistar rats (F+M) / 
Gavage 
70, 350, and 700 mg/kg 
bw/day (males only) 
Negative  (Beevers, 2012)  Valid study.in accordanace  with 
draft OECD Guideline 474 
(2012). and in compliance with 
GLP 
Top dose was the maximum 
tolerated. Systemic exposure 
indicated by liver function 
changes. 
Comet assay in 
rat liver 
Han Wistar rats (F+M) / 
Gavage 
70, 350, and 700 mg/kg 
bw/day (males only) 
Negative  (Beevers, 2012)  The study is in compliance with 
international accepted guidelines. 
and in compliance with GLP  
Top dose was maximum 
tolerated. Exposure to target 
organ indicated by liver function 
changes. 
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ABBREVIATIONS 
AFC    Food Additives, Flavourings, Processing Aids and Materials in Contact with Food 
CAS    Chemical Abstract Service 
CEF    Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CoE    Council of Europe 
DNA    Deoxyribonucleic acid 
EFSA    The European Food Safety Authority 
EU    European Union 
FGE    Flavouring Group Evaluation  
FLAVIS (FL)  Flavour Information System (database) 
GLP    Good Laboratory Practice 
ID    Identity 
IR    Infrared spectroscopy 
JECFA   The Joint FAO/WHO Expert Committee on Food Additives 
LMA    Low Melting point Agarose 
MNBN   MicroNucleated BiNucleate cells 
MS    Masse spectra 
MTD    Maximum Tolerated Dose 
NMA    Normal Melting point Agarose 
NMR    Nuclear Magnetic Resonance 
No    Number 
OECD    Organisation for Economic Co-operation and Development 
PCE    Polychromatic Erythrocytes 
(Q)SAR  (Quantitative ) Structure Activity Relationship 
RI    Replication Index 
SCF    Scientific Committee on Food 
WHO    World Health Organisation 